China To Formulate Implementation Plan On Health Care Reform
This article was originally published in PharmAsia News
Executive Summary
Nov. 14 was the deadline for submitting opinions on China's health care reform plan (PharmAsia News, Oct. 16, 08). Informed sources reveal that the reform team will formulate a new implementation plan on deepening health care system changes based on the existing draft and public comments. The new plan contains five supplementary files and could be made public by year end. In addition, the reform's leading ministry, National Development and Reform Commission, has begun to set timelines to deliver a more concrete and applicable implementation plan which will focus on reforms in the next three years. (Click here for more - Chinese Language)
You may also be interested in...
China Releases New Health Plan With Controls On ”Necessary Drugs”
Chinese officials unveiled a national health care-reform plan that would create a separate department for buying the nation's pharmaceuticals. Currently, that health sector is contained in one department along with the public health service, medical treatment and medical insurance. The draft proposal released for public debate envisions gradual increases in total health expenditures to reduce the burden on individuals. The plan includes a basic-medicine system listing necessary drugs to be made and distributed under government control and supervision to prevent efforts to circumvent government price controls. (Click here for more
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.